AInvest Newsletter
Daily stocks & crypto headlines, free to your inbox
Kits Eyecare Ltd. Q1 2025 Earnings Call Transcript: Roger Hardy, Joseph Thompson, and Zhe Choo Discuss Financial Results and Future Outlook.
ByAinvest
Wednesday, May 14, 2025 5:04 am ET1min read
Kits Eyecare Ltd. (KTYCF) reported Q1 2025 earnings, with Roger Hardy, Joseph Thompson, and Zhe Choo participating in the conference call. The call was hosted by Beacon Securities Limited, Canaccord Genuity Corp., ROTH Capital Partners, Stifel Nicolaus Canada Inc., Cormark Securities Inc., and Haywood Securities Inc. The company's financial results and forward-looking statements were discussed, with management cautioning investors not to rely on the latter due to potential material differences from actual results.
Kits Eyecare Ltd. (KTYCF) reported robust financial performance for Q1 2025, with revenue growing by 34% year-over-year to $46.6 million. The company's adjusted EBITDA margin reached 7.4%, the highest to date, reflecting strong operational efficiency. Gross profit surged by 53%, driven by a 460 basis point increase in gross margin to 36.7%.The company welcomed over 95,000 new customers, a 28% increase from the previous year, with 62% of total revenue coming from returning customers. The Kits Autoship program contributed nearly $6 million in revenue, up 11% year-over-year. Glasses units delivered increased by 39% to 104,000 pairs.
Marketing expenses rose to 13.5% of revenue, up from 13% last year, signaling continued investment in customer acquisition. However, general and administrative expenses decreased to 6.3% of revenue, down from 6.9% the previous year.
Kits Eyecare's stock price rose by 1.5% in after-hours trading following the earnings release, reflecting positive investor sentiment. The company's EPS of $0.05 exceeded the projected $0.0359, marking a 39.3% surprise.
Management expects Q2 2025 revenue between $48 million and $50 million, with an adjusted EBITDA margin of 3-5%. The company continues to invest in customer acquisition and aims for a long-term EBITDA margin target of 15-20%.
Reference List:
[1] https://finance.yahoo.com/news/kits-eyecare-ltd-ktycf-q1-071650917.html
[2] https://www.investing.com/news/transcripts/earnings-call-transcript-kits-eyecare-q1-2025-beats-eps-expectations-93CH-4029095
Ainvest News articles are AI-generated using advanced large language model (LLM) technology designed to analyze and synthesize publicly available data and news. While AI tools assist in producing initial drafts and insights, all AI generated content published on Ainvest is subject to comprehensive human editorial review before publication. A designated human editor reviews, verifies, and approves each article for factual accuracy, coherence, and compliance with AInvest Fintech Inc’s editorial and disclosure standards.
Despite these review procedures, the information provided may still contain inaccuracies, incomplete data, or time sensitive references due to the inherent limitations of AI generated analysis and evolving changes. The material is provided strictly for informational and educational purposes and does not constitute personalized investment, legal, or financial advice. Readers should independently verify all facts, figures, and statements before making any decision based on this content.
AInvest Fintech Inc. its affiliates, and partners accept no liability or responsibility for any direct or consequential losses arising from reliance on this content. All articles and analyses are subject to revision, update, or removal without prior notice to maintain accuracy and integrity in our publications.
Comments
No comments yet